Streamline Health Solutions, Inc. (STRM)
USD 2.28
(-0.71%)
USD 2.28
(-0.71%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 11.54 Million USD | -3.11% |
| 2022 | 11.49 Million USD | 30.58% |
| 2021 | 8.8 Million USD | 55.59% |
| 2020 | 5.65 Million USD | -57.35% |
| 2019 | 13.26 Million USD | -6.78% |
| 2018 | 14.22 Million USD | 0.45% |
| 2017 | 14.16 Million USD | -8.81% |
| 2016 | 15.53 Million USD | -8.17% |
| 2015 | 16.91 Million USD | 15.68% |
| 2014 | 14.62 Million USD | -4.54% |
| 2013 | 15.31 Million USD | 25.81% |
| 2012 | 12.17 Million USD | 47.88% |
| 2011 | 8.23 Million USD | 30.37% |
| 2010 | 6.31 Million USD | -26.06% |
| 2009 | 8.54 Million USD | 15.08% |
| 2008 | 7.42 Million USD | -12.46% |
| 2007 | 8.47 Million USD | -2.56% |
| 2006 | 8.7 Million USD | -10.21% |
| 2005 | 9.68 Million USD | 44.66% |
| 2004 | 6.69 Million USD | -11.46% |
| 2003 | 7.56 Million USD | -11.85% |
| 2002 | 8.58 Million USD | 28.37% |
| 2001 | 6.68 Million USD | 15.86% |
| 2000 | 5.77 Million USD | 37.4% |
| 1999 | 4.2 Million USD | 10.53% |
| 1998 | 3.8 Million USD | 72.73% |
| 1997 | 2.2 Million USD | -18.52% |
| 1996 | 2.7 Million USD | 42.11% |
| 1995 | 1.9 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 2.23 Million USD | -23.69% |
| 2024 Q2 | 2.09 Million USD | -6.13% |
| 2023 FY | 11.13 Million USD | -3.11% |
| 2023 Q4 | 2.92 Million USD | -10.02% |
| 2023 Q3 | 3.25 Million USD | 15.3% |
| 2023 Q2 | 2.82 Million USD | 10.88% |
| 2023 Q1 | 2.54 Million USD | -23.61% |
| 2022 FY | 11.49 Million USD | 30.58% |
| 2022 Q2 | 2.78 Million USD | 2.27% |
| 2022 Q1 | 2.72 Million USD | -8.06% |
| 2022 Q3 | 2.64 Million USD | -5.06% |
| 2022 Q4 | 3.33 Million USD | 25.92% |
| 2021 FY | 8.8 Million USD | 55.59% |
| 2021 Q1 | 1.51 Million USD | 9.31% |
| 2021 Q3 | 2.89 Million USD | 102.17% |
| 2021 Q2 | 1.43 Million USD | -5.55% |
| 2021 Q4 | 2.96 Million USD | 2.56% |
| 2020 Q3 | 1.16 Million USD | -24.3% |
| 2020 FY | 5.65 Million USD | -57.35% |
| 2020 Q1 | 1.57 Million USD | -36.84% |
| 2020 Q2 | 1.53 Million USD | -2.48% |
| 2020 Q4 | 1.38 Million USD | 19.19% |
| 2019 Q1 | 3.71 Million USD | -0.05% |
| 2019 Q3 | 4.02 Million USD | 32.65% |
| 2019 Q2 | 3.03 Million USD | -18.19% |
| 2019 FY | 13.26 Million USD | -6.78% |
| 2019 Q4 | 2.49 Million USD | -38.1% |
| 2018 Q2 | 3.13 Million USD | -20.64% |
| 2018 FY | 14.22 Million USD | 0.45% |
| 2018 Q4 | 3.71 Million USD | 8.09% |
| 2018 Q3 | 3.43 Million USD | 9.61% |
| 2018 Q1 | 3.94 Million USD | 5.85% |
| 2017 Q3 | 4.04 Million USD | 21.54% |
| 2017 Q2 | 3.33 Million USD | 8.99% |
| 2017 Q4 | 3.72 Million USD | -7.86% |
| 2017 FY | 14.16 Million USD | -8.81% |
| 2017 Q1 | 3.05 Million USD | -7.31% |
| 2016 Q3 | 3.41 Million USD | -30.11% |
| 2016 Q1 | 3.94 Million USD | 6.88% |
| 2016 Q2 | 4.88 Million USD | 23.9% |
| 2016 Q4 | 3.29 Million USD | -3.39% |
| 2016 FY | 15.53 Million USD | -8.17% |
| 2015 Q3 | 4.25 Million USD | -27.44% |
| 2015 Q2 | 5.85 Million USD | 88.09% |
| 2015 FY | 16.91 Million USD | 15.68% |
| 2015 Q4 | 3.68 Million USD | -13.27% |
| 2015 Q1 | 3.11 Million USD | -2.95% |
| 2014 Q3 | 3.79 Million USD | -10.14% |
| 2014 Q1 | 3.39 Million USD | 17.7% |
| 2014 FY | 14.62 Million USD | -4.54% |
| 2014 Q2 | 4.22 Million USD | 24.24% |
| 2014 Q4 | 3.21 Million USD | -15.37% |
| 2013 Q4 | 2.88 Million USD | -19.75% |
| 2013 FY | 15.31 Million USD | 25.81% |
| 2013 Q3 | 3.59 Million USD | -35.02% |
| 2013 Q2 | 5.53 Million USD | 67.93% |
| 2013 Q1 | 3.29 Million USD | 3.25% |
| 2012 Q2 | 2.69 Million USD | -3.85% |
| 2012 Q3 | 3.49 Million USD | 29.77% |
| 2012 Q4 | 3.19 Million USD | -8.57% |
| 2012 FY | 12.17 Million USD | 47.88% |
| 2012 Q1 | 2.79 Million USD | 21.88% |
| 2011 Q4 | 2.29 Million USD | 6.19% |
| 2011 FY | 8.23 Million USD | 30.37% |
| 2011 Q3 | 2.16 Million USD | 11.19% |
| 2011 Q2 | 1.94 Million USD | 6.35% |
| 2011 Q1 | 1.82 Million USD | 30.96% |
| 2010 Q2 | 2.04 Million USD | 111.51% |
| 2010 Q3 | 1.9 Million USD | -6.8% |
| 2010 Q4 | 1.39 Million USD | -26.74% |
| 2010 FY | 6.31 Million USD | -26.06% |
| 2010 Q1 | 966.88 Thousand USD | -73.19% |
| 2009 Q4 | 3.6 Million USD | 109.45% |
| 2009 Q3 | 1.72 Million USD | 6.2% |
| 2009 Q2 | 1.62 Million USD | 2.04% |
| 2009 FY | 8.54 Million USD | 15.08% |
| 2009 Q1 | 1.58 Million USD | 16.83% |
| 2008 Q1 | 1.5 Million USD | -53.88% |
| 2008 FY | 7.42 Million USD | -12.46% |
| 2008 Q2 | 2.46 Million USD | 63.87% |
| 2008 Q4 | 1.36 Million USD | -34.87% |
| 2008 Q3 | 2.08 Million USD | -15.34% |
| 2007 FY | 8.47 Million USD | -2.56% |
| 2007 Q4 | 3.26 Million USD | 52.81% |
| 2007 Q3 | 2.13 Million USD | 64.38% |
| 2007 Q2 | 1.29 Million USD | -26.87% |
| 2007 Q1 | 1.77 Million USD | -20.36% |
| 2006 Q2 | 2.5 Million USD | 18.98% |
| 2006 FY | 8.7 Million USD | -10.21% |
| 2006 Q4 | 2.23 Million USD | 19.74% |
| 2006 Q3 | 1.86 Million USD | -25.53% |
| 2006 Q1 | 2.1 Million USD | -49.96% |
| 2005 Q3 | 1.66 Million USD | -31.21% |
| 2005 Q2 | 2.41 Million USD | 72.21% |
| 2005 FY | 9.68 Million USD | 44.66% |
| 2005 Q1 | 1.4 Million USD | -44.1% |
| 2005 Q4 | 4.2 Million USD | 152.62% |
| 2004 Q1 | 1.38 Million USD | -38.02% |
| 2004 Q3 | 1.41 Million USD | 2.23% |
| 2004 Q4 | 2.51 Million USD | 77.49% |
| 2004 Q2 | 1.38 Million USD | -0.08% |
| 2004 FY | 6.69 Million USD | -11.46% |
| 2003 Q1 | 1.27 Million USD | -49.03% |
| 2003 Q4 | 2.23 Million USD | -7.2% |
| 2003 Q3 | 2.4 Million USD | 46.76% |
| 2003 Q2 | 1.64 Million USD | 28.32% |
| 2003 FY | 7.56 Million USD | -11.85% |
| 2002 Q2 | 2.09 Million USD | 11.55% |
| 2002 Q1 | 1.88 Million USD | 4.99% |
| 2002 Q3 | 2.09 Million USD | -0.36% |
| 2002 Q4 | 2.51 Million USD | 20.0% |
| 2002 FY | 8.58 Million USD | 28.37% |
| 2001 Q1 | 1.68 Million USD | -13.18% |
| 2001 FY | 6.68 Million USD | 15.86% |
| 2001 Q3 | 2.18 Million USD | 113.66% |
| 2001 Q2 | 1.02 Million USD | -39.14% |
| 2001 Q4 | 1.79 Million USD | -18.05% |
| 2000 Q4 | 1.93 Million USD | 14.22% |
| 2000 FY | 5.77 Million USD | 37.4% |
| 2000 Q1 | 852.58 Thousand USD | 184.2% |
| 2000 Q3 | 1.69 Million USD | 32.05% |
| 2000 Q2 | 1.28 Million USD | 50.66% |
| 1999 Q2 | 1 Million USD | -9.09% |
| 1999 Q1 | 1.1 Million USD | 37.5% |
| 1999 FY | 4.2 Million USD | 10.53% |
| 1999 Q4 | 300 Thousand USD | -83.33% |
| 1999 Q3 | 1.8 Million USD | 80.0% |
| 1998 Q3 | 900 Thousand USD | -10.0% |
| 1998 Q2 | 1 Million USD | -16.67% |
| 1998 Q1 | 1.2 Million USD | 50.0% |
| 1998 FY | 3.8 Million USD | 72.73% |
| 1998 Q4 | 800 Thousand USD | -11.11% |
| 1997 Q4 | 800 Thousand USD | 14.29% |
| 1997 Q1 | 600 Thousand USD | 500.0% |
| 1997 FY | 2.2 Million USD | -18.52% |
| 1997 Q3 | 700 Thousand USD | 600.0% |
| 1997 Q2 | 100 Thousand USD | -83.33% |
| 1996 Q1 | 600 Thousand USD | -77.78% |
| 1996 FY | 2.7 Million USD | 42.11% |
| 1996 Q3 | 700 Thousand USD | -41.67% |
| 1996 Q4 | 100 Thousand USD | -85.71% |
| 1996 Q2 | 1.2 Million USD | 100.0% |
| 1995 Q4 | 2.7 Million USD | 285.71% |
| 1995 Q2 | 1.2 Million USD | 200.0% |
| 1995 Q3 | 700 Thousand USD | -41.67% |
| 1995 FY | 1.9 Million USD | 0.0% |
| 1995 Q1 | 400 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Ontrak, Inc. | 8.8 Million USD | -31.17% |
| iCoreConnect Inc. | 6.12 Million USD | -88.536% |
| Augmedix, Inc. | 21.52 Million USD | 46.376% |
| BrightSpring Health Services, Inc. Common Stock | 1.43 Billion USD | 99.195% |
| CareCloud, Inc. | 46.24 Million USD | 75.038% |
| CareCloud, Inc. | 46.24 Million USD | 75.038% |
| HealthEquity, Inc. | 622.63 Million USD | 98.146% |
| Inovalon Holdings, Inc. | 499.7 Million USD | 97.69% |
| Nutex Health, Inc. | 34.77 Million USD | 66.806% |
| OneMedNet Corporation | -127.9 Thousand USD | 9125.02% |
| Progyny, Inc. | 238.79 Million USD | 95.166% |
| Omnicell, Inc. | 499.92 Million USD | 97.691% |
| Renalytix Plc | 156 Thousand USD | -7299.359% |
| Schrödinger, Inc. | 140.69 Million USD | 91.796% |
| Simulations Plus, Inc. | 43.15 Million USD | 73.25% |
| SOPHiA GENETICS SA | 42.91 Million USD | 73.101% |
| Minerva Surgical, Inc. | 27.24 Million USD | 57.628% |
| GE HealthCare Technologies Inc. | 7.92 Billion USD | 99.854% |
| Sharecare, Inc. | 129.49 Million USD | 91.086% |
| Aclarion, Inc. | -324.00 USD | 3562754.321% |
| CareMax, Inc. | 13.9 Million USD | 16.963% |
| Bullfrog AI Holdings, Inc. Common Stock | 59.8 Thousand USD | -19202.676% |
| Forian Inc. | 15 Million USD | 23.069% |
| Bullfrog AI Holdings, Inc. Warrants | 59.8 Thousand USD | -19202.676% |
| HeartBeam, Inc. | - USD | -Infinity% |
| GeneDx Holdings Corp. | 60.62 Million USD | 80.959% |
| SCWorx Corp. | 1.26 Million USD | -809.558% |
| Definitive Healthcare Corp. | 203.93 Million USD | 94.34% |
| 10x Genomics, Inc. | 409.31 Million USD | 97.18% |
| Zhongchao Inc. | 8.51 Million USD | -35.605% |
| Accolade, Inc. | 192.06 Million USD | 93.99% |
| MSP Recovery, Inc. | 5.56 Million USD | -107.608% |
| R1 RCM Inc. | 484.5 Million USD | 97.618% |
| Spok Holdings, Inc. | 112.2 Million USD | 89.713% |
| Privia Health Group, Inc. | 161.5 Million USD | 92.853% |
| EUDA Health Holdings Limited | 842.07 Thousand USD | -1270.781% |
| TruBridge, Inc. | 163.56 Million USD | 92.943% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 1.43 Billion USD | 99.195% |
| Sharecare, Inc. | 129.49 Million USD | 91.086% |
| Health Catalyst, Inc. | 131.83 Million USD | 91.244% |
| GoodRx Holdings, Inc. | 683.34 Million USD | 98.311% |
| Premier, Inc. | 840.73 Million USD | 98.627% |
| HealthStream, Inc. | 184.04 Million USD | 93.728% |
| Certara, Inc. | 213.31 Million USD | 94.589% |
| GeneDx Holdings Corp. | 60.62 Million USD | 80.959% |
| Ontrak, Inc. | 8.8 Million USD | -31.17% |
| SHL Telemedicine Ltd. | 25.26 Million USD | 54.305% |
| CareCloud, Inc. | 46.24 Million USD | 75.038% |
| EUDA Health Holdings Limited | 842.07 Thousand USD | -1270.781% |
| HeartBeam, Inc. | - USD | -Infinity% |
| Mangoceuticals, Inc. | 431.5 Thousand USD | -2575.081% |
| CareMax, Inc. | 13.9 Million USD | 16.963% |
| Healthcare Triangle, Inc. | 6.77 Million USD | -70.326% |
| National Research Corporation | 86.66 Million USD | 86.681% |
| Aclarion, Inc. | -324.00 USD | 3562754.321% |
| OptimizeRx Corporation | 42.89 Million USD | 73.093% |